Cumberland Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.42M Sell
3,000
-5,250
-64% -$2.64M 0.11% 105
2025
Q4
$3.85M Buy
8,250
+750
+10% +$348K 0.24% 85
2025
Q3
$3.2M Buy
7,500
+1,500
+25% +$581K 0.21% 84
2025
Q2
$2.3M Buy
+6,000
New +$2.16M 0.16% 96
2024
Q4
Sell
-3,500
Closed -$1.42M 182
2024
Q3
$1.42M Sell
3,500
-500
-13% -$183K 0.1% 121
2024
Q2
$1.29M Buy
+4,000
New +$1.3M 0.09% 114
2023
Q4
Sell
-6,132
Closed -$1.51M 182
2023
Q3
$1.51M Buy
6,132
+750
+14% +$205K 0.15% 103
2023
Q2
$1.63M Sell
5,382
-338
-6% -$94K 0.15% 99
2023
Q1
$1.51M Buy
5,720
+1,500
+36% +$381K 0.15% 93
2022
Q4
$1.01M Buy
+4,220
New +$945K 0.11% 104
2018
Q3
Sell
-7,000
Closed -$718K 193
2018
Q2
$718K Buy
+7,000
New +$708K 0.07% 117

Other funds holding HCA

Cumberland Partners's HCA Position: Q1 2026 in Review

Cumberland Partners reduced its HCA Healthcare (HCA) stake by 64% in Q1 2026, selling an estimated $2.64M and leaving 3,000 shares worth $1.42M. The position accounts for 0.11% of the portfolio, ranked #105.

Cumberland Partners first reported a position in HCA in Q2 2018 and has held it in 11 quarters since. The position peaked at $3.85M in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Cumberland Partners held 3,000 shares of HCA Healthcare worth $1.42M as of Q1 2026.
  • Cumberland Partners sold 5,250 HCA Healthcare shares in Q1 2026, an estimated $2.64M.
  • HCA Healthcare made up 0.11% of Cumberland Partners's portfolio in Q1 2026, its #105 holding.
  • Cumberland Partners first reported a position in HCA Healthcare in Q2 2018 and has held it in 11 quarters since.
  • Cumberland Partners's HCA Healthcare position peaked at $3.85M in Q4 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Cumberland Partners's 13F filing for Q1 2026, filed 14 May 2026.